| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 1.27e-03 | 39 | 27 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 1.68e-03 | 45 | 27 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.10e-03 | 190 | 27 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 2.67e-03 | 207 | 27 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.86e-03 | 212 | 27 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 3.47e-03 | 65 | 27 | 2 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.58e-03 | 66 | 27 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.58e-03 | 66 | 27 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.91e-03 | 69 | 27 | 2 | GO:0016278 | |
| HumanPheno | Pancreatic pseudocyst | 2.77e-05 | 5 | 9 | 2 | HP:0005206 | |
| HumanPheno | Pancreatic calcification | 9.93e-05 | 9 | 9 | 2 | HP:0005213 | |
| Domain | TRYPSIN_SER | 2.60e-04 | 90 | 26 | 3 | IPR033116 | |
| Domain | TRYPSIN_HIS | 3.86e-04 | 103 | 26 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 4.20e-04 | 106 | 26 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 4.32e-04 | 107 | 26 | 3 | PS00134 | |
| Domain | Peptidase_S1A | 5.07e-04 | 113 | 26 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 5.33e-04 | 115 | 26 | 3 | PS50240 | |
| Domain | Tryp_SPc | 5.61e-04 | 117 | 26 | 3 | SM00020 | |
| Domain | Trypsin | 6.18e-04 | 121 | 26 | 3 | PF00089 | |
| Domain | Trypsin_dom | 6.18e-04 | 121 | 26 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 6.49e-04 | 123 | 26 | 3 | IPR009003 | |
| Domain | SET_dom | 2.19e-03 | 50 | 26 | 2 | IPR001214 | |
| Domain | SET | 2.19e-03 | 50 | 26 | 2 | PS50280 | |
| Pathway | REACTOME_ALPHA_DEFENSINS | 1.15e-04 | 11 | 21 | 2 | MM14569 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 3.56e-04 | 19 | 21 | 2 | M27639 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 36191639 | ||
| Pubmed | Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. | 5.80e-07 | 2 | 27 | 2 | 18461367 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 33202925 | ||
| Pubmed | Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer. | 5.80e-07 | 2 | 27 | 2 | 15651064 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27846138 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 2598466 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20484960 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 14695529 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35089416 | ||
| Pubmed | Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. | 5.80e-07 | 2 | 27 | 2 | 18063422 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15776435 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 24146905 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 11073713 | ||
| Pubmed | The origin of trypsin: evidence for multiple gene duplications in trypsins. | 1.74e-06 | 3 | 27 | 2 | 9732462 | |
| Pubmed | Trypsin-mediated enzymatic degradation of type II collagen in the human vitreous. | 1.74e-06 | 3 | 27 | 2 | 23882137 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 26110235 | ||
| Pubmed | Divergent roles of SPINK1 and PRSS2 variants in tropical calcific pancreatitis. | 1.74e-06 | 3 | 27 | 2 | 19077465 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 1763044 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 33515547 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 3011602 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 25253127 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 22764252 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 22379635 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 23814066 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 18428024 | ||
| Pubmed | 8.82e-06 | 650 | 27 | 6 | 38777146 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 23143602 | ||
| Pubmed | 1.53e-05 | 62 | 27 | 3 | 19367581 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.75e-05 | 202 | 27 | 4 | 33005030 | |
| Pubmed | Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement. | 2.08e-05 | 9 | 27 | 2 | 11160223 | |
| Pubmed | 3.18e-05 | 11 | 27 | 2 | 19096130 | ||
| Pubmed | Blood pressure and hypertension are associated with 7 loci in the Japanese population. | 4.50e-05 | 13 | 27 | 2 | 20479155 | |
| Pubmed | 6.06e-05 | 15 | 27 | 2 | 24624459 | ||
| Pubmed | 6.92e-05 | 16 | 27 | 2 | 21572416 | ||
| Pubmed | Genome-wide association analysis identifies 13 new risk loci for schizophrenia. | 8.29e-05 | 109 | 27 | 3 | 23974872 | |
| Pubmed | Genome-wide association study reveals genetic risk underlying Parkinson's disease. | 1.09e-04 | 20 | 27 | 2 | 19915575 | |
| Pubmed | 1.59e-04 | 24 | 27 | 2 | 26506232 | ||
| Pubmed | 2.66e-04 | 31 | 27 | 2 | 19690177 | ||
| Pubmed | Genome-wide association study identifies eight loci associated with blood pressure. | 2.84e-04 | 32 | 27 | 2 | 19430483 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 2.90e-04 | 418 | 27 | 4 | 32552912 | |
| Pubmed | 5.09e-04 | 202 | 27 | 3 | 24639526 | ||
| Pubmed | Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. | 5.63e-04 | 45 | 27 | 2 | 21378990 | |
| Pubmed | 6.40e-04 | 48 | 27 | 2 | 24262325 | ||
| Pubmed | 7.23e-04 | 51 | 27 | 2 | 36896912 | ||
| Cytoband | 7q34 | 4.35e-03 | 167 | 27 | 2 | 7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 4.92e-03 | 178 | 27 | 2 | chr2q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 5.31e-03 | 185 | 27 | 2 | chr7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 5.53e-03 | 189 | 27 | 2 | chr10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.48e-02 | 316 | 27 | 2 | chr3p21 | |
| GeneFamily | Proteases, serine | 3.75e-05 | 63 | 19 | 3 | 738 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 7.55e-06 | 387 | 27 | 6 | GSM538392_500 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 176 | 27 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 178 | 27 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 182 | 27 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 182 | 27 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 189 | 27 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 5.01e-06 | 190 | 27 | 4 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.88e-05 | 144 | 27 | 3 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 154 | 27 | 3 | a39877cdf7b441b5c953f744ed30f1d5acf4ea19 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 160 | 27 | 3 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 160 | 27 | 3 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 1.28e-04 | 163 | 27 | 3 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 164 | 27 | 3 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 164 | 27 | 3 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 164 | 27 | 3 | 7a51365bad2910c130bd952805f7a1bef51be481 | |
| ToppCell | mild_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 1.38e-04 | 167 | 27 | 3 | 69330689b6e353c8ee9ea1b63a5eac6ab38d456f | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 169 | 27 | 3 | dbf9b1d52b29bf4b60bd23012cc1ea82d344747f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 169 | 27 | 3 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 71e5e27c3c4e6cc8dc9b063bd51c21c049f54416 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 255bbbd00d0e17510c5a8c5faa43ed90d887a9de | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | aff226a84e397ab58204325aa9d8b396a881986e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 170 | 27 | 3 | 9a21048b0248a0cae00ec2d71d5056a678495385 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 170 | 27 | 3 | aeac9de12efc727313946a77823aba8ab7cdfbfb | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 170 | 27 | 3 | 6af16e6f276aec6389ece99505ba13c7edc4c4fa | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 1.50e-04 | 172 | 27 | 3 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 174 | 27 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-Activated_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 176 | 27 | 3 | 6802ed40eb0f91674d4f0120a3d4888c8a2e9612 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 1.61e-04 | 176 | 27 | 3 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.63e-04 | 177 | 27 | 3 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 178 | 27 | 3 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 178 | 27 | 3 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 181 | 27 | 3 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-04 | 186 | 27 | 3 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 187 | 27 | 3 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 1.92e-04 | 187 | 27 | 3 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 27 | 3 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 188 | 27 | 3 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-04 | 188 | 27 | 3 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-04 | 188 | 27 | 3 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-04 | 188 | 27 | 3 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.95e-04 | 188 | 27 | 3 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 27 | 3 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 188 | 27 | 3 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.98e-04 | 189 | 27 | 3 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-04 | 189 | 27 | 3 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.98e-04 | 189 | 27 | 3 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.98e-04 | 189 | 27 | 3 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-04 | 189 | 27 | 3 | c604da558c9f4055fb36218452463539f2a73223 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 2.01e-04 | 190 | 27 | 3 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-04 | 190 | 27 | 3 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-Treg|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.01e-04 | 190 | 27 | 3 | 8540f4dee99280109e38b997d9247b176808c51a | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 2.01e-04 | 190 | 27 | 3 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 190 | 27 | 3 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 2.04e-04 | 191 | 27 | 3 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 191 | 27 | 3 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 191 | 27 | 3 | 011dc22c488369734749e839d65d52fe46b6a1a4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 192 | 27 | 3 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | Mild/Remission-B_naive-11|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.08e-04 | 192 | 27 | 3 | c6f325cddce43b72f013b21dfffc9987fd68b6a7 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 192 | 27 | 3 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 192 | 27 | 3 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 2.08e-04 | 192 | 27 | 3 | 04bd6e135733570e877af9460f87379ed0a5c5f8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 192 | 27 | 3 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.08e-04 | 192 | 27 | 3 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 192 | 27 | 3 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 2.11e-04 | 193 | 27 | 3 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 2.11e-04 | 193 | 27 | 3 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 2.11e-04 | 193 | 27 | 3 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | IIH-CD8-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 2.11e-04 | 193 | 27 | 3 | c5a4926003906d6726155f19061b73fb45d9962c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 193 | 27 | 3 | 778fcf8448e81fe18972d97ea8a30ab036d16fe5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.11e-04 | 193 | 27 | 3 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 194 | 27 | 3 | fa72c2f3e6b8bfc2ef126deb219ec6a44809385b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 194 | 27 | 3 | 64535db0420e53e4d777d2333b5051e63e8a3373 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.14e-04 | 194 | 27 | 3 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 194 | 27 | 3 | 13c3674d601c8a7355ce869de1af6401938c0037 | |
| ToppCell | MS-CD8|MS / Condition, Cell_class and T cell subcluster | 2.14e-04 | 194 | 27 | 3 | 8dfeaa213403cedecb1976bfde1bac84f0155999 | |
| ToppCell | B_cell_maturation-Naive_B_cell|B_cell_maturation / Lineage and Cell class | 2.14e-04 | 194 | 27 | 3 | adb6f9aff65276e0db1f8367149998938b8e4fb0 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.14e-04 | 194 | 27 | 3 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.14e-04 | 194 | 27 | 3 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 194 | 27 | 3 | b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 194 | 27 | 3 | bc7c4efe2a82057fb95582da983e36f413990902 | |
| ToppCell | MS-CD8-CD8_1|MS / Condition, Cell_class and T cell subcluster | 2.14e-04 | 194 | 27 | 3 | 9c05eb30c4b5c6fc410b83cb8aa8138bd46527c9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 194 | 27 | 3 | b43788e458a80ab93f485f4577370aec448ad95e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 2.14e-04 | 194 | 27 | 3 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.17e-04 | 195 | 27 | 3 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | (0)_NK|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.20e-04 | 196 | 27 | 3 | e2578a562d9903a33a7c60db229005680af8141c | |
| ToppCell | (0)_NK_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.20e-04 | 196 | 27 | 3 | 9b080859130cf156bfa833dc71fd39734cb9a32d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 196 | 27 | 3 | bbdc92ec2e95ed7d782df0c72d94f9a9d9439bf0 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.20e-04 | 196 | 27 | 3 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-04 | 196 | 27 | 3 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.20e-04 | 196 | 27 | 3 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-04 | 196 | 27 | 3 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 197 | 27 | 3 | 2abe27f6722fa0dab801bca4cd19e34c1fb4173e | |
| Computational | Neighborhood of SERPINI2 | 6.11e-04 | 25 | 16 | 2 | GNF2_SERPINI2 | |
| Computational | Neighborhood of SPINK1 | 7.13e-04 | 27 | 16 | 2 | GNF2_SPINK1 | |
| Drug | AC1Q637U | 3.25e-07 | 12 | 27 | 3 | CID000004869 | |
| Drug | AC1L1ESB | 4.22e-07 | 13 | 27 | 3 | CID000002926 | |
| Drug | N-allylglycine | 4.06e-06 | 3 | 27 | 2 | CID000076651 | |
| Drug | N-phosphopyridoxyl-L-serine | 4.06e-06 | 3 | 27 | 2 | CID000195946 | |
| Drug | Z-Arg-OH | 4.06e-06 | 3 | 27 | 2 | CID000071055 | |
| Drug | GB-107 | 4.06e-06 | 3 | 27 | 2 | CID000056813 | |
| Drug | N-acetyl-L-norvaline methyl ester | 4.06e-06 | 3 | 27 | 2 | CID000150916 | |
| Drug | YAKR-CK | 4.06e-06 | 3 | 27 | 2 | CID005487256 | |
| Drug | p-amidinophenylpyruvate | 4.06e-06 | 3 | 27 | 2 | CID000444106 | |
| Drug | schizopeptin 791 | 4.06e-06 | 3 | 27 | 2 | CID000636821 | |
| Drug | v 1194 | 4.06e-06 | 3 | 27 | 2 | CID000074702 | |
| Drug | mitorubrinic acid | 4.06e-06 | 3 | 27 | 2 | CID000379537 | |
| Drug | 2 alpha-bromoacetoxyprogesterone | 4.06e-06 | 3 | 27 | 2 | CID000135256 | |
| Drug | Lapg-nh2 | 4.06e-06 | 3 | 27 | 2 | CID003082486 | |
| Drug | Methotrexate-polylysine | 4.06e-06 | 3 | 27 | 2 | CID000163214 | |
| Drug | methyl octanesulfonate | 4.06e-06 | 3 | 27 | 2 | CID000165858 | |
| Drug | ASA-PE | 4.06e-06 | 3 | 27 | 2 | CID003037809 | |
| Drug | 3HFGB | 4.06e-06 | 3 | 27 | 2 | CID000126268 | |
| Drug | L-TAPA | 4.06e-06 | 3 | 27 | 2 | CID000193734 | |
| Drug | 4-chlorobenzenediazonium hexafluorophosphate | 4.06e-06 | 3 | 27 | 2 | CID002723983 | |
| Drug | methyl lignocerate | 4.06e-06 | 3 | 27 | 2 | CID000075546 | |
| Drug | 10-(carboxyethyl)flavin | 4.06e-06 | 3 | 27 | 2 | CID003082170 | |
| Drug | Z-Lys-CH2Cl | 4.06e-06 | 3 | 27 | 2 | CID000127335 | |
| Drug | 2,6-dimethyl-3-pyridinol | 4.06e-06 | 3 | 27 | 2 | CID000070732 | |
| Drug | K-13 | 6.54e-06 | 31 | 27 | 3 | CID000469669 | |
| Drug | AC1NUUB8 | 6.54e-06 | 31 | 27 | 3 | CID005493639 | |
| Drug | AC1LAOUV | 8.11e-06 | 4 | 27 | 2 | CID000492408 | |
| Drug | 5'-S-propynyl-5'-thioadenosine | 8.11e-06 | 4 | 27 | 2 | CID000492409 | |
| Drug | bromomesaconic acid | 8.11e-06 | 4 | 27 | 2 | CID006449799 | |
| Drug | 4-Amino-3-nitrobenzoic acid | 8.11e-06 | 4 | 27 | 2 | CID000074115 | |
| Drug | 4-ethylpiperidine | 8.11e-06 | 4 | 27 | 2 | CID000076704 | |
| Drug | N-carbobenzoxyglycine vinyl ester | 8.11e-06 | 4 | 27 | 2 | CID000047309 | |
| Drug | torquatone | 8.11e-06 | 4 | 27 | 2 | CID000256516 | |
| Drug | AC1Q5JO7 | 8.11e-06 | 4 | 27 | 2 | CID000128324 | |
| Drug | Dsdgk | 8.11e-06 | 4 | 27 | 2 | CID000130454 | |
| Drug | mGBSOM | 8.11e-06 | 4 | 27 | 2 | CID003080804 | |
| Drug | NSC-13568 | 8.11e-06 | 4 | 27 | 2 | CID000224783 | |
| Drug | Ba-O | 8.11e-06 | 4 | 27 | 2 | CID000002280 | |
| Drug | NSC-45351 | 8.11e-06 | 4 | 27 | 2 | CID000018046 | |
| Drug | xylaric acid | 8.11e-06 | 4 | 27 | 2 | CID003084064 | |
| Drug | indomethacin-NHS | 8.11e-06 | 4 | 27 | 2 | CID000128571 | |
| Drug | AC1MRIIV | 1.32e-05 | 39 | 27 | 3 | CID003518584 | |
| Drug | M 93 | 1.35e-05 | 5 | 27 | 2 | CID006444952 | |
| Drug | 6-amidinoindole | 1.35e-05 | 5 | 27 | 2 | CID003018291 | |
| Drug | Ag-B | 1.35e-05 | 5 | 27 | 2 | CID000004286 | |
| Drug | beta-Neuroprotectin | 1.35e-05 | 5 | 27 | 2 | CID005748443 | |
| Drug | 2,6-diphenoxypyridine | 1.35e-05 | 5 | 27 | 2 | CID000824772 | |
| Drug | Sr 42128 | 1.35e-05 | 5 | 27 | 2 | CID005487043 | |
| Drug | 4-TGPAP | 1.35e-05 | 5 | 27 | 2 | CID000132086 | |
| Drug | PTA-Arg | 1.35e-05 | 5 | 27 | 2 | CID000194378 | |
| Drug | AC1L3UIZ | 1.35e-05 | 5 | 27 | 2 | CID000147121 | |
| Drug | Ile-Phe-Lys-CH2Cl | 1.35e-05 | 5 | 27 | 2 | CID000124393 | |
| Drug | I 333 | 1.35e-05 | 5 | 27 | 2 | CID000533915 | |
| Drug | N-(5'-carboxypentyl)-1-deoxynojirimycin | 1.35e-05 | 5 | 27 | 2 | CID000133177 | |
| Drug | rho-guanidinobenzoate | 1.35e-05 | 5 | 27 | 2 | CID005311472 | |
| Drug | PTA-GPA | 1.35e-05 | 5 | 27 | 2 | CID000139330 | |
| Drug | Meebdp | 1.35e-05 | 5 | 27 | 2 | CID000132560 | |
| Drug | propynyl benzoate | 1.35e-05 | 5 | 27 | 2 | CID000196666 | |
| Drug | 2 up | 2.03e-05 | 6 | 27 | 2 | CID000193409 | |
| Drug | N-benzoyltyrosine butylamide | 2.03e-05 | 6 | 27 | 2 | CID000125261 | |
| Drug | Circulin A | 2.03e-05 | 6 | 27 | 2 | CID000065155 | |
| Drug | N-benzoyl-L-tyrosine thiobenzyl ester | 2.03e-05 | 6 | 27 | 2 | CID000191444 | |
| Drug | azidobestatin | 2.03e-05 | 6 | 27 | 2 | CID000132261 | |
| Drug | 2-azidoatrazine | 2.03e-05 | 6 | 27 | 2 | CID003032432 | |
| Drug | 4-TAPAP | 2.03e-05 | 6 | 27 | 2 | CID000133476 | |
| Drug | Ag2SO4 | 2.03e-05 | 6 | 27 | 2 | CID000159275 | |
| Drug | Db04336 | 2.03e-05 | 6 | 27 | 2 | CID000002014 | |
| Drug | N,N-dimethylglycylbenzocaine | 2.03e-05 | 6 | 27 | 2 | CID000188251 | |
| Drug | Ile-val | 2.64e-05 | 49 | 27 | 3 | CID000435949 | |
| Drug | bz-Ar | 2.83e-05 | 7 | 27 | 2 | CID000137302 | |
| Drug | bromobutide | 2.83e-05 | 7 | 27 | 2 | CID000053079 | |
| Drug | leupeptins | 2.83e-05 | 7 | 27 | 2 | CID003033938 | |
| Drug | Arg-OEt | 2.83e-05 | 7 | 27 | 2 | CID000439495 | |
| Drug | Inhibitor 61 | 2.83e-05 | 7 | 27 | 2 | CID005327349 | |
| Drug | Kki 7 | 2.83e-05 | 7 | 27 | 2 | CID003082667 | |
| Drug | Z-Glu-Tyr | 2.83e-05 | 7 | 27 | 2 | CID000096820 | |
| Drug | Kki 8 | 2.83e-05 | 7 | 27 | 2 | CID000064584 | |
| Drug | Gly-Gly-Arg | 2.83e-05 | 7 | 27 | 2 | CID000133469 | |
| Drug | Cbz-phe-arg-chn2 | 2.83e-05 | 7 | 27 | 2 | CID005492392 | |
| Drug | O-4-(ethoxybutyl)berbamine | 2.83e-05 | 7 | 27 | 2 | CID000188375 | |
| Drug | pentaammineaquocobalt(III) tetrafluoroborate | 2.83e-05 | 7 | 27 | 2 | CID000412963 | |
| Drug | TISCH | 2.98e-05 | 51 | 27 | 3 | CID000125486 | |
| Drug | 3,5-bis-trifluoromethylphenylboronic acid | 3.78e-05 | 8 | 27 | 2 | CID000156265 | |
| Drug | AC1MCHYW | 3.78e-05 | 8 | 27 | 2 | CID002770087 | |
| Drug | harderoporphyrin | 3.78e-05 | 8 | 27 | 2 | CID003081462 | |
| Drug | Boc hydrazine | 3.78e-05 | 8 | 27 | 2 | CID000070091 | |
| Drug | HMTi | 3.78e-05 | 8 | 27 | 2 | CID000195636 | |
| Drug | O-methyl-L-serine | 3.78e-05 | 8 | 27 | 2 | CID000088250 | |
| Drug | AC1NDMP4 | 3.78e-05 | 8 | 27 | 2 | CID004628293 | |
| Drug | Bio-Phe-CH2Cl | 3.78e-05 | 8 | 27 | 2 | CID000083924 | |
| Drug | Bio-Arg-CH2Cl | 3.78e-05 | 8 | 27 | 2 | CID000083923 | |
| Drug | AC1L9R2Z | 4.40e-05 | 168 | 27 | 4 | CID000453624 | |
| Drug | PtdIns(3,5)P | 4.85e-05 | 9 | 27 | 2 | CID000643961 | |
| Drug | 4Amf | 4.85e-05 | 9 | 27 | 2 | CID000150955 | |
| Drug | AC1MJ5M1 | 4.85e-05 | 9 | 27 | 2 | CID003086119 | |
| Drug | p-guanidino-L-phenylalanine | 4.85e-05 | 9 | 27 | 2 | CID000165028 | |
| Drug | tlmE | 4.85e-05 | 9 | 27 | 2 | CID000188322 | |
| Drug | FK-401 | 4.85e-05 | 9 | 27 | 2 | CID000135041 | |
| Drug | dansyl-L-arginine | 4.85e-05 | 9 | 27 | 2 | CID000119895 | |
| Drug | Surfynol | 4.85e-05 | 9 | 27 | 2 | CID000061018 | |
| Disease | Hereditary pancreatitis | 6.88e-06 | 5 | 25 | 2 | cv:C0238339 | |
| Disease | PANCREATITIS, HEREDITARY | 6.88e-06 | 5 | 25 | 2 | 167800 | |
| Disease | Autosomal Dominant Hereditary Pancreatitis | 6.88e-06 | 5 | 25 | 2 | C4080064 | |
| Disease | Hereditary pancreatitis | 1.44e-05 | 7 | 25 | 2 | C0238339 | |
| Disease | Pancreatitis, Chronic | 2.47e-05 | 9 | 25 | 2 | C0149521 | |
| Disease | epilepsy (implicated_via_orthology) | 3.48e-04 | 163 | 25 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | unipolar depression, systolic blood pressure | 3.80e-04 | 34 | 25 | 2 | EFO_0003761, EFO_0006335 | |
| Disease | anxiety | 8.66e-04 | 223 | 25 | 3 | EFO_0005230 | |
| Disease | methadone dose measurement | 1.26e-03 | 62 | 25 | 2 | EFO_0007907 | |
| Disease | Manic | 1.99e-03 | 78 | 25 | 2 | C0338831 | |
| Disease | coronary artery disease | 2.91e-03 | 1194 | 25 | 5 | EFO_0001645 | |
| Disease | mean fractional anisotropy measurement | 2.93e-03 | 95 | 25 | 2 | EFO_0008399 | |
| Disease | alcoholic pancreatitis | 3.12e-03 | 98 | 25 | 2 | EFO_1002013 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.26e-03 | 355 | 25 | 3 | EFO_0004784, EFO_0008354 | |
| Disease | endometrial carcinoma | 4.12e-03 | 113 | 25 | 2 | EFO_1001512 | |
| Disease | white matter microstructure measurement | 4.25e-03 | 390 | 25 | 3 | EFO_0005674 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKGPAAIQKNYSPYY | 191 | P35527 | |
| GLKKNVYEQQKYYGM | 3411 | Q9UPA5 | |
| AKQKGYVPFYVNATA | 331 | Q99259 | |
| QAKYKAFVAYQKYGP | 291 | Q96JM4 | |
| ETPQLYYKYKQVAPK | 396 | Q6WRI0 | |
| PTKRQKYGVAIYNYN | 6 | Q9H7D0 | |
| KNGFKVYVYPQQKGE | 111 | Q16394 | |
| NNFFKLQKKYGPIYS | 51 | P05093 | |
| IKPNAITYGYYNKVV | 851 | Q5VZ89 | |
| YGKPVNDYSKYINKE | 1701 | Q99698 | |
| KVYYKDGKQLPNSYN | 131 | Q96P31 | |
| YYKDIKQYVFTTQNP | 61 | Q9NQ60 | |
| NQYFQKEKIQGEYKY | 186 | Q08211 | |
| LKQYLPNIAYSYDKQ | 256 | Q8NE22 | |
| APEAYVQKYVVKNYF | 71 | Q8IWX5 | |
| FYNSQGPKYNFQKSK | 531 | Q0VFZ6 | |
| EKNKKAPEYYLYQRN | 666 | Q9H8M5 | |
| IQNQHKYSIKYNPGY | 901 | Q8IZH2 | |
| NQFTKYSYKYKDQPQ | 456 | Q9NY15 | |
| GNKYFKAGKYEQAIQ | 121 | O94826 | |
| AQKNRPGVYTKVYNY | 221 | P07478 | |
| KSLPGVYTNVIYYQK | 246 | Q7RTY5 | |
| YDQNYAGNKPVKYQL | 126 | Q7L2R6 | |
| AQKNKPGVYTKVYNY | 221 | P07477 | |
| RYIVKNPQAYLNYKV | 1321 | Q12789 | |
| QYGQKIIKPYSKHYP | 361 | Q9NRG4 | |
| YYYANEKSKQPKGTF | 141 | Q86WV1 |